These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3092196)

  • 1. Clinical studies with human growth hormone releasing factor in normal adults and patients.
    Sassolas G; Biot-Laporte S; Cohen R; Chatelain P; Boissel JP; Ferry S; Chayvialle JA; Dupin P; Garry P; Claustrat B
    Peptides; 1986; 7 Suppl 1():281-6. PubMed ID: 3092196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of human growth hormone releasing factor in adults.
    Sassolas G; Biot-Laporte S; Cohen R; Chatelain P; Boissel JP; Dupin P; Garry P; Claustrat B; Girard P; Borson F
    Horm Res; 1986; 24(2-3):99-111. PubMed ID: 3093356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
    Vance ML; Kaiser DL; Evans WS; Furlanetto R; Vale W; Rivier J; Thorner MO
    J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on growth hormone secretion following intravenous and subcutaneous injections of growth hormone-releasing factor (hGRF-44 NH2): comparison of immunoreactive plasma GRF levels.
    Sassolas G; Biot-Laporte S; Cohen R; Elm Charfi A; Ferry S; Borson F
    Clin Endocrinol (Oxf); 1985 May; 22(5):645-53. PubMed ID: 3928209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
    Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
    J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men.
    Hartman ML; Farello G; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1378-84. PubMed ID: 1592884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of theophylline infusion on the growth hormone (GH) and prolactin response to GH-releasing hormone administration in acromegaly.
    Losa M; Alba-Lopez J; Schopohl J; Sobiesczcyk S; Chiodini PG; Müller OA; von Werder K
    J Endocrinol Invest; 1988 Oct; 11(9):663-7. PubMed ID: 3146595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men.
    Evans WS; Vance ML; Kaiser DL; Sellers RP; Borges JL; Downs TR; Frohman LA; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1985 Nov; 61(5):846-50. PubMed ID: 3930551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma GH and somatomedin C responses to single and repeated administrations of human growth hormone releasing factor (hGRF).
    Takano K; Hizuka N; Shizume K; Hirose N; Ling NC
    Endocrinol Jpn; 1985 Feb; 32(1):73-80. PubMed ID: 3926476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
    Losa M; Alba-Roth J; Sobieszczyk S; Schopohl J; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):383-9. PubMed ID: 2494827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose response of two synthetic human growth hormone-releasing factors on growth hormone release in heifers and pigs.
    Peticlerc D; Pelletier G; Lapierre H; Gaudreau P; Couture Y; Dubreuil P; Morisset J; Brazeau P
    J Anim Sci; 1987 Oct; 65(4):996-1005. PubMed ID: 2889716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion.
    Katakami H; Arimura A; Frohman LA
    Endocrinology; 1986 May; 118(5):1872-7. PubMed ID: 3084210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man.
    Giustina A; Bossoni S; Bodini C; Doga M; Girelli A; Buffoli MG; Schettino M; Wehrenberg WB
    Metabolism; 1991 May; 40(5):519-23. PubMed ID: 2023538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human pancreatic tumor growth hormone-releasing hormone (hpGRH1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men.
    Sassolas G; Chatelain P; Cohen R; Boissel JP; Laporte S; Galleyrand J; Claustrat B; Elmcharfi A; Chayvialle JA; Cohen H
    J Clin Endocrinol Metab; 1984 Oct; 59(4):705-9. PubMed ID: 6148353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism and diurnal variations of human growth hormone-releasing factor (1-29)NH2 and thyrotropin-releasing factor on growth hormone release in dairy calves.
    Lapierre H; Petitclerc D; Pelletier G; Dubreuil P; Morisset J; Gaudreau P; Couture Y; Brazeau P
    Domest Anim Endocrinol; 1987 Oct; 4(4):207-14. PubMed ID: 2907311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous growth hormone-releasing hormone augments pulsatile nocturnal GH release in GH-insufficient children, but may also raise basal GH secretion.
    Ross RJ; Kirk JM; Tsagarakis S; Trainer PJ; Ciccarelli E; Touzel R; Grossman A; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):239-48. PubMed ID: 2225481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone releasing factor stimulates and somatostatin inhibits prolactin release from human mixed somatotroph-lactotroph adenomas in perifusion.
    Serri O
    Clin Endocrinol (Oxf); 1987 Dec; 27(6):675-82. PubMed ID: 2901301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic human growth hormone releasing factor (h-GRF-I-44-NH2) dose response effect on growth hormone and prolactin secretion in healthy adult men.
    Boissel JP; Cohen R; Biot-Laporte S; Claustrat B; Renard H; Olivier M; Sassolas G
    Eur J Clin Pharmacol; 1986; 29(5):609-14. PubMed ID: 3082645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
    Stachura ME; Tyler JM; Farmer PK
    Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.